PLoS Negl Trop Dis March 2023 PMID 36972285

Randomized trial evaluating an mHealth intervention for the early community-based detection and follow-up of cutaneous leishmaniasis in rural Colombia.

Mabel Castillo, Neal Alexander, Luisa Rubiano, Carlos Rojas, Andrés Navarro, Domiciano Rincon, Leonardo Vargas Bernal, Yenifer Orobio Lerma, Nancy Gore Saravia, Eliah Aronoff-Spencer

Mentions

3
Peak: 2 in Mar 2023
across 2 sources since Mar 2023

Extended reach

5,091
potential audience

Total likes

3

Video views

15

Mentions per month

Mar 2023 – Jul 2023

Where it's discussed

  • X / Twitter2 posts
  • YouTube1 videos

AI synopsis

What people are saying

Several discussions praise the study's findings, describing the app as a 'game changer' for rural health, while others note the importance of technology in addressing healthcare gaps. The tone is optimistic and emphasizes practical implications, reflecting strong interest and perceived high impact, with some users engaging deeply by analyzing the methodology and outcomes.

AgreementModerate agreement

Most discussions support the positive findings of the study, highlighting that the app effectively improved disease monitoring and outcomes.

InterestHigh interest

The topic engages a high level of interest due to its relevance to healthcare advancements in rural areas and digital solutions.

EngagementModerate engagement

The discussions reflect a moderate depth, with users referencing specific aspects like community-based detection and treatment success, indicating thoughtful engagement.

ImpactHigh impact

Many posts emphasize the significant potential impact of mHealth tools in improving access to healthcare and disease management in underserved populations.

Abstract in brief

  • This study tested an app called Guaral ST for Android, designed to help monitor and follow up on treatment for cutaneous leishmaniasis (CL) in rural Colombia, where access to healthcare is limited.
  • The randomized trial compared a mobile health (mHealth) app-based follow-up approach with standard healthcare methods, finding that the app significantly increased the number of patients monitored and improved treatment outcomes, with most patients in the intervention group being cured.
  • The results demonstrate that mHealth tools like the app can effectively improve disease management and care delivery in remote settings, with no serious adverse effects observed among patients monitored using the app.]

Top posts

Most liked on X and Bluesky
Fernando Suárez Obando
@FerSuarezMD · X

Randomized trial evaluating an mHealth intervention for the early community-based detection and follow-up of cutaneous leishmaniasis in rural Colombia #ColombiaEnPubmed https://t.co/EJ4iGqU1UF

Mar 28, 2023 · 3 likes · 4,867 followers View post →
Digital Health Evidence
@digitalhealthev · X

Randomized trial evaluating an mHealth intervention for the early community-based detection and follow-up of cutaneous leishmaniasis in rural Colombia. https://t.co/UALKoANs4p

Mar 27, 2023 · 209 followers View post →

All mentions

Fernando Suárez Obando
@FerSuarezMD · X

Randomized trial evaluating an mHealth intervention for the early community-based detection and follow-up of cutaneous leishmaniasis in rural Colombia #ColombiaEnPubmed https://t.co/EJ4iGqU1UF

Mar 28, 2023 · 3 likes · 4,867 followers View post →
Digital Health Evidence
@digitalhealthev · X

Randomized trial evaluating an mHealth intervention for the early community-based detection and follow-up of cutaneous leishmaniasis in rural Colombia. https://t.co/UALKoANs4p

Mar 27, 2023 · 209 followers View post →